Form 4 for CNTX Context Therapeutics Inc.
Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-16 · accession 0001842952-21-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-12-20 | 2021-12-16 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $3.22 | +13.0K | 820.2K | +2% | +$41.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-16 | P | A | 13,000 | $3.22 | 820,190 | I Martin Lehr 2000 Trust | — | — |